| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2014 | US8709812 Drug comprising as the active ingredient proliferative vector containing survivin promoter |
| 04/29/2014 | US8709776 Polypeptides having beta-glucosidase activity and beta-xylosidase activity and polynucleotides encoding same |
| 04/29/2014 | US8709773 DFPase enzymes from Aplysia californica |
| 04/29/2014 | US8709759 Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins |
| 04/29/2014 | US8709757 Method for producing interferon alpha 5 |
| 04/29/2014 | US8709752 Process for producing dipeptides or dipeptide derivatives |
| 04/29/2014 | US8709737 Bitter taste receptors |
| 04/29/2014 | US8709710 Methods of modulating interleukin-22 and immune response by notch regulators |
| 04/29/2014 | US8709492 Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals |
| 04/29/2014 | US8709484 Phospholipid-based powders for drug delivery |
| 04/29/2014 | US8709483 System for targeted delivery of therapeutic agents |
| 04/29/2014 | US8709464 Porous objects having immobilized encapsulated biomolecules |
| 04/29/2014 | US8709446 HYR1 as a target for active and passive immunization against Candida |
| 04/29/2014 | US8709442 Recombinant negative strand virus RNA expression systems and vaccines |
| 04/29/2014 | US8709435 Hypallergenic mosaic antigens and methods of making same |
| 04/29/2014 | US8709433 Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate |
| 04/29/2014 | US8709432 Methods for increasing efficacy of FOLR1 cancer therapy |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709417 Combination immunotherapy for the treatment of cancer |
| 04/29/2014 | US8709408 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 04/29/2014 | US8709407 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof |
| 04/29/2014 | US8709406 Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes |
| 04/29/2014 | US8709405 Cancer vaccines containing epitopes of oncofetal antigen |
| 04/29/2014 | US8709342 Antimicrobial flush solutions |
| 04/29/2014 | US8709310 Spray drying vancomycin |
| 04/29/2014 | US8708994 Method for altering drug pharmacokinetics based on medical delivery platform |
| 04/29/2014 | CA2789115C Microporation of tissue for delivery of bioactive agents |
| 04/29/2014 | CA2681746C Prophylactic agent for heart failure |
| 04/29/2014 | CA2618561C A process for the preparation of perindopril erbumine |
| 04/29/2014 | CA2609456C Localized delivery of cardiac inotropic agents |
| 04/29/2014 | CA2554809C Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase |
| 04/29/2014 | CA2551916C Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 04/29/2014 | CA2542942C Nucleic acids useful for triggering tumor cell lethality |
| 04/29/2014 | CA2534907C Homogeneous preparations of il-28 and il-29 |
| 04/29/2014 | CA2481556C Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/29/2014 | CA2472381C Glycosyltransferase gnt-v having neovascularization action |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/29/2014 | CA2232048C Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 04/26/2014 | CA2829371A1 Methods for preventing and treating post-traumatic stress disorder (ptsd) |
| 04/24/2014 | WO2014063147A1 New antiviral macrocycles |
| 04/24/2014 | WO2014063108A1 Methods of using a fixed dose of a clotting factor |
| 04/24/2014 | WO2014063071A1 Treatment of depression and ptsd |
| 04/24/2014 | WO2014063012A1 Conjugated knottin mini-proteins containing non-natural amino acids |
| 04/24/2014 | WO2014062870A2 Treatment of brain injury or trauma with tsg-6 protein |
| 04/24/2014 | WO2014062696A1 Polymeric treatment compositions |
| 04/24/2014 | WO2014062621A1 Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits |
| 04/24/2014 | WO2014062587A2 Injectable cancer compositions |
| 04/24/2014 | WO2014062424A1 Flowable formulations for tissue repair and regeneration |
| 04/24/2014 | WO2014062196A1 Hepatitis c virus inhibitors |
| 04/24/2014 | WO2014062080A1 Medicated wound-healing aid for treating wounds and burns |
| 04/24/2014 | WO2014061772A1 Novel nk3 receptor agonist |
| 04/24/2014 | WO2014061749A1 Synthetic peptide capable of suppressing expression of tnf receptor type-2, and use thereof |
| 04/24/2014 | WO2014061735A1 NOVEL HIGH-FUNCTIONING ENZYME HAVING ALTERED HUMAN β-HEXOSAMINIDASE B SUBSTRATE SPECIFICITY, AND HAVING PROTEASE RESISTANCE APPLIED THERETO |
| 04/24/2014 | WO2014060610A2 Antimicrobial peptides |
| 04/24/2014 | WO2014060601A1 Compositions and methods for drug delivery |
| 04/24/2014 | WO2014060512A1 Fatty acid acylated amino acids for growth hormone delivery |
| 04/24/2014 | WO2014060509A1 Use of a bioactivated phytochemical as a neuroprotective agent for preventing and treating disorders related to nervous system |
| 04/24/2014 | WO2014060472A1 Fatty acid acylated amino acids for oral peptide delivery |
| 04/24/2014 | WO2014060447A1 Fatty acid acylated d-amino acids for oral peptide delivery |
| 04/24/2014 | WO2014060401A1 Coagulation factor vii polypeptides |
| 04/24/2014 | WO2014060392A1 Caspase-6 inhibitors for treating t cell activation and/or proliferation disorders |
| 04/24/2014 | WO2014060109A1 Gene therapy for glycogen storage diseases |
| 04/24/2014 | WO2014059928A1 Anticancer and anti-obesity cyclic peptide agents |
| 04/24/2014 | WO2014059536A1 Combination of an insulin and tissue kallikrein 1 |
| 04/24/2014 | WO2014059530A1 Derivatives of collagen-binding hairpin peptides |
| 04/24/2014 | WO2014014819A3 Methods of treating glucose metabolism disorders |
| 04/24/2014 | WO2012145665A3 Method of drug delivery for pth, pthrp and related peptides |
| 04/24/2014 | WO2012122044A3 Flowable collagen-based hemostat and methods of use |
| 04/24/2014 | WO2012116225A3 Muc1 based glycolipopeptide vaccine with adjuvant |
| 04/24/2014 | WO2012106313A3 Ubiquitin interacting motif peptides as cancer therapeutics |
| 04/24/2014 | WO2012078703A3 Inhibiting chromosome instability in ovarian cancer |
| 04/24/2014 | US20140114233 Methods and systems for toxin delivery to the nasal cavity |
| 04/24/2014 | US20140114208 Method of treating vision disorders |
| 04/24/2014 | US20140113975 Biodegradable block copolymeric compositions for drug delivery |
| 04/24/2014 | US20140113923 Novel antiviral therapies |
| 04/24/2014 | US20140113874 Modified Compstatin With Improved Stability And Binding Properties |
| 04/24/2014 | US20140113873 Chitin binding proteins and methods of use |
| 04/24/2014 | US20140113870 METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST |
| 04/24/2014 | US20140113867 Apls for treating arthritis |
| 04/24/2014 | US20140113866 Novel application of reduced-fat soybean protein material to soybean-derived raw material-containing food or beverage |
| 04/24/2014 | US20140113865 Use of pertussis toxin as a therapeutic agent |
| 04/24/2014 | US20140113864 Injectable Depot Composition |
| 04/24/2014 | US20140113863 Methods comprising desmopressin |
| 04/24/2014 | US20140113861 Cartilage product |
| 04/24/2014 | US20140113859 Use of liver growth factor (lgf) as a neural tissue regenerator |
| 04/24/2014 | US20140113857 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9 |
| 04/24/2014 | US20140113856 Magnesium Compositions for Modulating the Pharmacokinetics and Pharmacodynamics of Insulin and Insulin Analogs, and Injection Site Pain |
| 04/24/2014 | US20140113855 Modified Release Formulations for Oprozomib |
| 04/24/2014 | US20140113330 Modified vitamin k-dependent polypeptides |
| 04/24/2014 | US20140112998 Methods of modulating bone remodeling |
| 04/24/2014 | US20140112976 Cyclic Peptides with an Anti-Neoplasic and Anti-Angiogenic Activity |
| 04/24/2014 | US20140112951 Vaccine and drug delivery by topical application of vectors and vector extracts |
| 04/24/2014 | US20140112944 Compositions and methods for treating cancer |
| 04/24/2014 | US20140112939 Methods for Inhibiting Osteolysis |
| 04/24/2014 | US20140112919 Interleukin-10 antibodies |
| 04/24/2014 | US20140112908 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 04/24/2014 | US20140112907 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 04/24/2014 | US20140112906 Prostatic Acid Phosphatase for the Treatment of Pain |
| 04/24/2014 | US20140112905 Prostatic Acid Phosphatase for the Treatment of Pain |
| 04/24/2014 | US20140112904 Method for enhancing the cleavage activity of i-crei derived meganucleases |